June 12, 2020: The Week in Cancer News
The American Cancer Society issues guidelines for diet and physical activity, and more cancer news of the week from Cancer Today.
Progress Against Cancer
The American Cancer Society issues guidelines for diet and physical activity, and more cancer news of the week from Cancer Today.
Immune checkpoint inhibitors kill cancer cells by releasing the brakes on the immune system, thereby allowing it to mount an antitumor response. This form of immunotherapy has led to dramatic responses in some patients; however, most patients’ tumors do not respond to immune checkpoint inhibition, and resistance can develop in tumors that initially respond.
Some people with early-stage non-small cell lung cancer can benefit significantly from treatment with a targeted therapy, and more news of the week from Cancer Today.
In the early 1990s, Gregg Semenza, MD, PhD, was a postdoctoral researcher studying the cellular response to reduced oxygen levels, a state known as hypoxia. His focus was on the erythropoietin gene, EPO, which controls red blood cell production, and thus oxygen delivery. After identifying a sequence within the EPO gene that was critical for the response to hypoxia, Semenza isolated a mystery protein that was bound to this sequence.
A study shows that a more tolerable, dose-adjusted chemotherapy regimen can effectively treat a rare lymphoma, and more news of the week from Cancer Today.
The days are getting longer and warmer, and visions of beach trips, cookouts, and picnics occupy our minds. While this year’s summer will likely look different due to the ongoing COVID-19 pandemic, months of staying inside may make the desire to head outside even stronger.
Signaling pathways that regulate cellular proliferation are commonly mutated in cancer cells, leading to unrestrained cellular division and tumor growth. Therefore, insight into the regulation of these signaling pathways is critical to the development of novel therapeutics. Mutations in the RAS...
Metastatic prostate cancer incidence rose after changes to prostate cancer screening guidelines.
A study indicates that children with cancer are not at increased risks of severe cases of COVID-19, and more news of the week from Cancer Today.
In the United States, nearly 24,000 people are estimated to receive a brain or nervous system cancer diagnosis in 2020. Even though these cancers represent only about 1 percent of all new cancer cases, brain and other nervous system cancers are the ninth leading cause of cancer-related mortality.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More